SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-20-008530
Filing Date
2020-02-11
Accepted
2020-02-11 19:48:47
Documents
2
Period of Report
2020-02-11

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1619
2 POA DOCUMENT poa.txt EX-24.3_893916 2999
  Complete submission text file 0001209191-20-008530.txt   6098
Mailing Address 1 LITTLE WEST 12TH STREET NEW YORK NY 10014
Business Address 1 LITTLE WEST 12TH STREET NEW YORK NY 10014 646-844-0337
ArTara Therapeutics, Inc. (Issuer) CIK: 0001359931 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O ARTARA THERAPEUTICS, INC. 1 LITTLE WEST 12TH STREET NEW YORK NY 10014
Business Address
Davis Blaine (Reporting) CIK: 0001802188 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36694 | Film No.: 20599422